StockIQ.techElanco Animal Health Incorporated (ELAN) Stock Analysis
Free AI-powered analysis and research for Elanco Animal Health Incorporated stock
Sector: Healthcare
ELAN snapshot
Data as of 3 Nov 2026 close. Updated daily.
Elanco Animal Health Incorporated scores 49/100 on StockIQ's model, which reads as mixed signals overall. The price is above its 200-day average and at 61% of its 52-week range, up 7.9% over the past year. Latest reported figures show a profit margin of -4.0%, return on equity of -3.0% and revenue growth of +10.2%.
What is driving the score
- Uptrend: +4
- MACD Bullish: +8
- Unprofitable (-4.0%): -15
- Strong Liquidity (2.05 Current Ratio): +8
- Negative ROE (-3.0%): -10
- Above MA200: +4
- Up Over 1 Year (+7.9%): +3
- Low Volume (0.5x): -3
Automated, general information only – not financial advice. Scores can be wrong. How the score works
Full ELAN report
Elanco Animal Health Incorporated (ELAN) is listed in the Healthcare sector. The snapshot on this page updates daily; run a full report for the complete breakdown.
Analyze ELAN Now →📰 Latest Update
Elanco Animal Health Incorporated (ELAN) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
Fri, October 30, 2026 at 1:00 PM UTC 2 min read
Elanco Animal Health Incorporated (ELAN) is set to release its earnings report next week, with analysts projecting significant growth in earnings. This anticipated increase is crucial for investors as it may indicate strong demand for Elanco's animal health products and could positively impact the company's stock performance. Investors should monitor the earnings release closely to assess the company's financial health and future growth potential.